Please login to the form below

Not currently logged in
Email:
Password:

insulin

This page shows the latest insulin news and features for those working in and with pharma, biotech and healthcare.

Sanofi Global Health unveils new nonprofit Impact brand

Sanofi Global Health unveils new nonprofit Impact brand

Impact will enable 30 Sanofi medicines to be distributed to 40 lower-income countries, including insulin, glibenclamide and oxaliplatin, which are considered essential by WHO.

Latest news

More from news
Approximately 75 fully matching, plus 483 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest appointments

  • New hires at Amgen, Eli Lilly and Zosano New hires at Amgen, Eli Lilly and Zosano

    During his time at Lilly, Mason has led its connected care business and steered its efforts to improve insulin affordability.This includes the creation of the Lilly Diabetes Solution Center, to ... support people in need of less expensive alternatives to

  • Ashfield, Health Unlimited and Ashley Communications add to their teams Ashfield, Health Unlimited and Ashley Communications add to their teams

    Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK diabetes team.

  • Emperra appoints Bent Johnsen as CEO Emperra appoints Bent Johnsen as CEO

    Johnsen’s expertise lies in the health care sector and he has held several executive leadership positions within the field of diabetes working for insulin manufacturing companies as well as other

  • Novo Nordisk appoints Liz Skrbkova Novo Nordisk appoints Liz Skrbkova

    She will move from the company's UK team to take up a role in Søborg, Denmark, where she will focus on the company's modern insulin and device portfolio.

  • Adocia names senior members of new US subsidiary Adocia names senior members of new US subsidiary

    He joins from Halozyme Pharmaceuticals, where he held the position of executive medical director and worked on the ultra-rapid insulin programme. ... He most recently served as VP of commercial at Halozyme, also on the ultra-rapid insulin programme.

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...